A349 Phase I/II Trial of Perifosine + Bortezomib in Rel/Ref MM Patients Previously Treated with Bortezomib

Autor:	Aparna Krishnan, K O'Riley, Jeffrey L. Wolf, Robert L. Schlossman, NC Munshi, D. Irwin, Jeffrey A. Zonder, Jacob P. Laubach, L. Gardner, John J. Densmore, KC Anderson, D Tocco, Tara Kendall, Irene M. Ghobrial, Peter Sportelli, Dixil Francis, Noopur Raje, Teru Hideshima, Andrzej Jakubowiak, P. G. Richardson, Thomas Martin, S. Lonial, Kathleen Colson, E Steinfield, S Dean, Michael Bar
Rok vydání:	2009
Předmět:	Cancer Research business.industry Bortezomib Hematology General Medicine Perifosine chemistry.chemical_compound Phase i ii Oncology chemistry Cancer research Medicine business Previously treated medicine.drug
Zdroj:	Clinical Lymphoma and Myeloma. 9:S57
ISSN:	1557-9190
DOI:	10.1016/s1557-9190(11)70554-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e2e8930f3f338b38eaafafe309545040 https://doi.org/10.1016/s1557-9190(11)70554-6 Zobrazit plný text záznamu Full Text from ScienceDirect